日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells

撤稿声明:Dclk1是一种肿瘤干细胞标志物,可调节肠道肿瘤细胞的促生存信号传导和自我更新。

Chandrakesan, Parthasarathy; Yao, Jiannan; Qu, Dongfeng; May, Randal; Weygant, Nathaniel; Ge, Yang; Ali, Naushad; Sureban, Sripathi M; Gude, Modhi; Vega, Kenneth; Bannerman-Menson, Eddie; Xia, Lijun; Bronze, Michael; An, Guangyu; Houchen, Courtney W

A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growth.

一种新型 D 肽调节 DCLK1 凝溶胶蛋白相互作用,从而减少 PDAC 肿瘤生长。

Moore Landon L, Qu Dongfeng, Chandrekesan Parthasarathy, Pitts Kamille, May Randal, Anderson Byron E, Brown Milton L, Houchen Courtney W

A Novel D-peptide modulates DCLK1 Gelsolin interactions, reducing PDAC tumor growth.

一种新型D肽调节DCLK1与凝溶胶蛋白的相互作用,从而减少PDAC肿瘤的生长

Moore Landon L, Qu Dongfeng, Chandrekesan Parthasarathy, Pitts Kamille, May Randal, Anderson Byron E, Brown Milton, Houchen Courtney W

Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral Activity

深入了解肿瘤内催化乳酸耗竭对代谢重编程和免疫激活抗肿瘤活性的影响

Junlong Zhao, Zhimin Tian, Shoujie Zhao, Dayun Feng, Zhixiong Guo, Liangzhi Wen, Yejing Zhu, Fenghua Xu, Jun Zhu, Shouzheng Ma, Jie Hu, Tao Jiang, Yongquan Qu, Dongfeng Chen, Lei Liu

DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization

DCLK1-Isoform2 选择性剪接变体促进胰腺肿瘤免疫抑制性 M2 巨噬细胞极化

Chandrakesan, Parthasarathy; Panneerselvam, Janani; May, Randal; Weygant, Nathaniel; Qu, Dongfeng; Berry, William R; Pitts, Kamille; Stanger, Ben Z; Rao, Chinthalapally V; Bronze, Michael S; Houchen, Courtney W

DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4

DCLK1通过ABCD-Member-4调控非小细胞肺癌的肿瘤干性和顺铂耐药性。

Panneerselvam, Janani; Mohandoss, Priyanga; Patel, Ravi; Gillan, Hamza; Li, Michael; Kumar, Kirtana; Nguyen, DangHuy; Weygant, Nathaniel; Qu, Dongfeng; Pitts, Kamille; Lightfoot, Stanley; Rao, Chinthalapally; Houchen, Courtney; Bronze, Michael; Chandrakesan, Parthasarathy

Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments

癌症干细胞标志物DCLK1与结肠癌和胃腺癌微环境中的致瘤免疫浸润相关

Wu, Xiangyan; Qu, Dongfeng; Weygant, Nathaniel; Peng, Jun; Houchen, Courtney W

Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer

DCLK1的替代剪接变体可标记癌症干细胞,促进自我更新和耐药性,并可作为抑制肾癌肿瘤发生的靶点。

Ge, Yang; Weygant, Nathaniel; Qu, Dongfeng; May, Randal; Berry, William L; Yao, Jiannan; Chandrakesan, Parthasarathy; Zheng, Wei; Zhao, Lichao; Zhao, Karena L; Drake, Michael; Vega, Kenneth J; Bronze, Michael S; Tomasek, James J; An, Guangyu; Houchen, Courtney W

Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells

Dclk1是一种肿瘤干细胞标志物,它调控肠道肿瘤细胞的促生存信号传导和自我更新。

Chandrakesan, Parthasarathy; Yao, Jiannan; Qu, Dongfeng; May, Randal; Weygant, Nathaniel; Ge, Yang; Ali, Naushad; Sureban, Sripathi M; Gude, Modhi; Vega, Kenneth; Bannerman-Menson, Eddie; Xia, Lijun; Bronze, Michael; An, Guangyu; Houchen, Courtney W

Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase

胃肠道癌症患者的生存期可通过DCLK1激酶标记的癌症干细胞样细胞的替代microRNA特征进行预测

Weygant, Nathaniel; Ge, Yang; Qu, Dongfeng; Kaddis, John S; Berry, William L; May, Randal; Chandrakesan, Parthasarathy; Bannerman-Menson, Edwin; Vega, Kenneth J; Tomasek, James J; Bronze, Michael S; An, Guangyu; Houchen, Courtney W